View Article

  • Synthesis, Characterization and Biological Activities of Substituted Imidazole Derivatives: A Review Manuscript

  • Dattakala College of Pharmacy Pune-Solapur Highway, Swami-Chincholi (Bhigwan), Tal-Daund, Dist-Pune, Maharashtra Pin code -413130.

Abstract

Imidazole is a compact five-membered 1,3-diazole heterocycle that has maintained strong importance in medicinal chemistry because its two nitrogen atoms provide hydrogen-bonding, basic, coordination and electronic features required for target binding. Substituted imidazole derivatives are frequently reported as antimicrobial, antifungal, anti-inflammatory, anticancer, antitubercular, antiviral, antidiabetic and enzyme-inhibitory molecules. The present manuscript provides a publication-oriented review of substituted imidazole derivatives with emphasis on basic introduction, synthetic routes, FT-IR and NMR characterization, biological activity profile, structure-activity relationship and review-based results. Classical Debus-Radziszewski condensation, N-substitution, hybrid molecule design, microwave-assisted synthesis, ultrasound-assisted synthesis and green catalytic approaches are discussed as major routes for generating imidazole libraries. Characterization is organized around TLC, melting point, FT-IR, 1H NMR, 13C NMR, mass spectrometry and elemental analysis. The biological section highlights antibacterial, antifungal, anti-inflammatory, anticancer, antitubercular and antiviral relevance while cautioning that in vitro zones and MIC values should not be overinterpreted without purity, solvent control, cytotoxicity and mechanistic validation. The review result indicates that electron-withdrawing substituents, halogenated aryl rings, heteroaryl hybrids and balanced lipophilicity frequently improve activity, whereas poor solubility, limited toxicity data and incomplete mechanism confirmation remain major limitations. This manuscript therefore presents imidazole derivatives as valuable pharmacophores for further lead optimization, provided that synthesis, spectral proof and standardized biological testing are integrated in a reproducible manner. [1-8]

Keywords

imidazole derivatives; heterocycles; FT-IR; 1H NMR; antimicrobial activity; SAR; biological evaluation; review.

Introduction

× Popup Image

Heterocyclic compounds occupy a central position in medicinal chemistry because the introduction of heteroatoms can strongly modify polarity, electron density, hydrogen-bonding behaviour, ionization and interaction with biological macromolecules. Among such scaffolds, imidazole is especially important because it is a small aromatic system containing two nitrogen atoms with different electronic roles. One nitrogen behaves in a pyridine-like manner, while the other contributes pyrrole-like electron density to the aromatic ring. This arrangement allows imidazole derivatives to participate in proton transfer, metal coordination, hydrogen bonding, pi-stacking and enzyme-site recognition. [1,2]

The therapeutic relevance of the imidazole nucleus is visible in well-known drugs such as metronidazole, clotrimazole, ketoconazole, miconazole, tinidazole, losartan and several investigational molecules. In antimicrobial research, imidazole derivatives are particularly attractive because the ring can be attached to aryl, heteroaryl, thiazole, pyrazole, Schiff-base, nitro, halogenated and metal-binding fragments. These substitutions can change membrane penetration, fungal sterol interaction, bacterial enzyme affinity and redox behaviour. [5-8]

Antimicrobial resistance has increased the need for new scaffolds, hybrid pharmacophores and mechanisms that are distinct from conventional antibiotics. Substituted imidazoles are useful in this setting because medicinal chemists can vary N-1, C-2, C-4 and C-5 substitution without losing the aromatic character of the ring. The same scaffold can also be redirected toward antifungal, antitubercular, antiviral, anti-inflammatory and anticancer activity by altering substituent electronics and lipophilicity. [6-12]

The objective of this review manuscript is to present a compact but complete publication-style article on imidazole derivatives. The manuscript includes a basic introduction, chemistry, synthesis, IR and NMR interpretation, activity profile, review-based result and an original flow diagram. It is intentionally written as a review-based research paper; therefore, no fabricated laboratory yield, melting point, MIC or spectral data are inserted. Instead, the results section summarizes what the reviewed literature supports and what future experimental work should validate.

2. Chemistry of the Imidazole Nucleus:

Imidazole has the molecular formula C3H4N2 and molecular weight 68.08 g/mol. It is a planar aromatic heterocycle containing six pi electrons, and this aromatic stabilization explains why many substitutions are tolerated without destroying the ring system. The imidazole ring is amphoteric in a practical medicinal-chemistry sense: it can act as a weak base through the pyridine-like nitrogen and can contribute hydrogen bonding through an N-H unit when not N-substituted. [1,2]

The pKa of the conjugate acid of imidazole is close to physiological relevance, making many imidazole derivatives partially ionizable under biological conditions. This feature may support aqueous solubility and target engagement, but excessive basicity or lipophilicity may also cause off-target binding and toxicity. Thus, medicinal optimization of imidazoles requires a balance among potency, solubility, permeability and safety.

 

Property

Typical feature

Importance in derivative design

Ring type

Five-membered 1,3-diazole

Provides compact aromatic pharmacophore.

Nitrogen pattern

One pyridine-like N and one pyrrole-like N

Supports hydrogen bonding, protonation and metal binding.

Aromaticity

Six pi-electron system

Allows stable substituted analogues.

Substitution sites

N-1, C-2, C-4 and C-5

Permits rapid SAR development.

Medicinal value

Present in antifungal, antiprotozoal and antihypertensive drugs

Shows scaffold adaptability across therapeutic areas.

 

The biological versatility of imidazole derivatives is not due to the ring alone. Activity generally emerges from the combination of the imidazole core with substituents that govern target selectivity. For example, halogens may improve lipophilicity and membrane interaction, nitro groups may support redox activity in specific antimicrobial contexts, and heteroaryl fusion may create additional enzyme-binding contacts. [6,7,10]

3. Rationale, Aim and Objectives:

The rationale for this review is based on the continuous appearance of imidazole derivatives in medicinal chemistry papers and the need to present a clear manuscript that connects synthesis with characterization and biological activity. Many short articles describe active compounds but do not clearly integrate IR interpretation, NMR evidence, antimicrobial testing parameters and SAR-based discussion. A publication-ready review must connect all these components in a systematic order.

Aim:

To review the synthesis, characterization and biological activity profile of substituted imidazole derivatives with special emphasis on IR, NMR and activity-related discussion suitable for manuscript preparation.

Objectives:

To describe the chemical importance of the imidazole nucleus in drug design.

To summarize classical and modern routes for preparing substituted imidazoles.

To explain how FT-IR, 1H NMR, 13C NMR and mass spectrometry confirm imidazole structures.

To organize the major biological activities reported for imidazole derivatives.

To present review-based results, SAR observations, limitations and future research directions.

This manuscript has been designed as a review paper and not as an original wet-laboratory synthesis report. Therefore, actual experimental values such as yield percentage, melting point, MIC or spectral chemical shifts should be inserted only when obtained from a laboratory batch or when reproduced from a cited article with clear attribution. This avoids the scientific risk of fabricated data and makes the manuscript more suitable for ethical submission.

4. Review Methodology:

A narrative review approach was adopted because the subject crosses medicinal chemistry, heterocyclic synthesis, analytical characterization and pharmacological screening. Priority was given to literature that clearly reports imidazole synthesis, characterization, antimicrobial or other biological testing, and structure-activity relationship. Recent studies published during 2024-2026 were also considered to identify current research trends. [12,13,24,27]

The manuscript was arranged according to standard article flow: title, abstract, keywords, introduction, chemistry, synthesis, characterization, biological activities, review result, discussion, conclusion and references. The review also includes an original flow diagram showing how literature evidence should be organized from synthetic design to activity result.

 

 

 

 

 

 

Inclusion focus

Reason for inclusion

Example information extracted

Synthesis papers

Show practical access to substituted imidazoles.

Reactants, catalysts, route type and product class.

Characterization papers

Confirm the analytical proof expected for publication.

FT-IR, 1H NMR, 13C NMR, MS and elemental analysis.

Activity papers

Identify biological scope and assay expectations.

Organism, assay, MIC, standard drug and controls.

Review papers

Summarize broad pharmacological trends.

Activity classes, SAR patterns and limitations.

Guideline/method papers

Support standardized biological testing.

Diffusion, dilution, MIC and quality-control principles.

 

The review avoids unverified numerical claims. Where the literature does not provide a reliable numerical value, the discussion is limited to qualitative interpretation. This is important because antimicrobial activity can be influenced by assay medium, inoculum, solvent, diffusion capacity, compound purity and incubation conditions. [19-21]

5. Original Flow Diagram

The following original diagram summarizes the recommended manuscript logic for substituted imidazole derivative research. It starts with literature and scaffold selection, moves through route mapping and spectral characterization, then connects activity evidence with SAR interpretation and review-based conclusions.

 

 

 

Figure 1. Original flow diagram for organizing synthesis, characterization, biological activity and review-based results of substituted imidazole derivatives.

 

The diagram is intended for a review manuscript and not as a laboratory protocol. In experimental papers, each box should be supported by batch-specific data such as reaction conditions, purity, spectra and validated biological results. In review writing, each box should be supported by properly cited studies and a clear explanation of how the evidence was interpreted.

6. Classical Synthesis of Substituted Imidazole Derivatives:

The Debus-Radziszewski imidazole synthesis is one of the most recognized classical routes for constructing imidazole rings. The general approach condenses a 1,2-dicarbonyl compound, an aldehyde and an ammonia source such as ammonium acetate to generate 2,4,5-trisubstituted imidazoles. When a primary amine is introduced, N-substituted or tetrasubstituted analogues can be accessed depending on substrate design and reaction conditions. [3,4]

General reaction concept:

1,2-dicarbonyl compound + aldehyde + ammonium acetate or ammonia source -> substituted imidazole derivative.

Mechanistically, the reaction involves imine formation, condensation, cyclization and aromatization. Its continued importance comes from convergent construction of a heteroaromatic ring in one pot. By changing the aldehyde, amine or dicarbonyl partner, a library of imidazole derivatives can be prepared for biological screening.

 

Route

Typical starting materials

Main advantage

Common limitation

Debus-Radziszewski condensation

Benzil/glyoxal + aldehyde + NH4OAc

One-pot ring formation and easy diversification.

May require heat, acid or tedious purification.

N-alkylation or N-acylation

Imidazole + alkyl/acyl reagent

Rapid N-substituent variation.

Over-alkylation and regioselectivity issues.

Hybrid synthesis

Imidazole linked with pyrazole, thiazole, indole or Schiff base

Broadens biological profile.

Longer synthetic route and more characterization.

Cyclocondensation methods

Amidines, alpha-haloketones or related intermediates

Useful for specific substitution patterns.

Substrate-dependent optimization required.

 

7. Green, Microwave and Ultrasound-Assisted Synthesis:

Recent imidazole chemistry has increasingly moved toward cleaner and faster synthetic approaches. Green chemistry strategies include solvent-free reactions, ethanol or water as safer media, recyclable heterogeneous catalysts, biopolymer-supported catalysts, nanocatalysts and microwave or ultrasound energy. These methods can shorten reaction time and reduce solvent waste, but their superiority must be supported by yield, purity, catalyst reuse and scalability data. [14-18]

Ultrasound-assisted imidazole synthesis has been reviewed as a method that improves mass transfer, accelerates condensation and may reduce reaction time compared with conventional heating. Microwave-assisted synthesis may also improve conversion and reduce time, although scale-up and hot-spot control must be evaluated carefully. [14]

 

Green parameter

Preferred practice

Manuscript reporting requirement

Solvent

Water, ethanol, solvent-free or benign solvent

State solvent volume and work-up method.

Catalyst

Reusable solid acid, chitosan, ionic liquid or nanocatalyst

Report catalyst loading and reuse cycles.

Energy input

Microwave or ultrasound when optimized

Mention power, time, temperature and equipment.

Purification

Crystallization where possible

Avoid excessive chromatography when greener option works.

Safety

Reduced corrosive acid and toxic solvent exposure

Discuss residue removal before biological testing.

 

For biological screening, residual catalysts and solvents must be controlled because they can independently inhibit microbes or affect cell viability. Therefore, a green synthesis claim is incomplete unless product purity and absence of interfering residues are demonstrated by appropriate analytical techniques.

8. Characterization Strategy for Imidazole Derivatives:

Proper characterization is essential before biological testing. A compound should not be evaluated as a novel derivative unless formation of the target structure has been supported by more than one analytical technique. TLC and melting point provide preliminary evidence of purity, while FT-IR, 1H NMR, 13C NMR and mass spectrometry provide structural confirmation. Elemental analysis or high-resolution mass spectrometry adds further support for molecular formula confirmation.

 

Technique

Information obtained

Relevance in imidazole manuscript

TLC

Reaction completion and purity trend

Shows disappearance of starting material and single product spot.

Melting point

Identity and purity indication

Sharp range supports a reasonably pure crystalline product.

FT-IR

Functional-group evidence

C=N, N-H, C-N, aryl C=C and substituent bands.

1H NMR

Proton environment

Aromatic protons, N-H, alkyl, methoxy or substituent protons.

13C NMR

Carbon skeleton

Imidazole carbons, aryl carbons and carbonyl/alkoxy carbons.

Mass spectrometry

Molecular ion and fragments

Confirms molecular weight and fragmentation pattern.

Elemental analysis

C, H, N composition

Supports empirical formula and product purity.

 

A publication-ready manuscript should assign spectral peaks rather than simply listing them. For example, disappearance of an aldehydic proton and appearance of imidazole/aromatic signals support cyclization. A molecular ion peak consistent with the calculated molecular weight strengthens the assignment. [9-13]

9. FT-IR Interpretation:

FT-IR spectroscopy is a rapid tool for confirming major functional groups in substituted imidazole derivatives. Imidazole C=N stretching commonly appears in the 1600-1650 cm-1 region, although the exact position changes with substitution, conjugation and hydrogen bonding. Aromatic C=C stretching may appear around 1450-1600 cm-1, and C-N stretching may be observed in the 1200-1350 cm-1 region. A free imidazole N-H group may show broad stretching around 3200-3400 cm-1, while N-substituted compounds may lack this band.

 

Structural feature

Typical FT-IR clue

Interpretation

Imidazole C=N

Approx. 1600-1650 cm-1

Supports heteroaromatic imine-type bond.

N-H stretch

Approx. 3200-3400 cm-1

Present when imidazole N-H remains unsubstituted.

Aryl C=C

Approx. 1450-1600 cm-1

Confirms aromatic substituent or phenyl rings.

C-N stretch

Approx. 1200-1350 cm-1

Supports C-N framework in heterocycle.

NO2 group

Asymmetric and symmetric nitro bands

Useful for nitro-substituted aryl imidazoles.

Methoxy group

C-O stretching band

Supports anisyl or alkoxy substitution.

Halogenated aryl

C-Cl/C-Br lower-frequency region

Supports halo-substituted analogues with MS isotope pattern.

 

IR alone is not sufficient to prove a new imidazole structure, because many aromatic and imine-like compounds show overlapping bands. However, it is valuable when interpreted together with NMR and MS. In a manuscript, IR peaks should be assigned to structural features, and the same compound code should be used across the synthetic table, IR table, NMR table and biological result table.

10. 1H NMR and 13C NMR Interpretation:

NMR spectroscopy is the most important routine method for structural confirmation of substituted imidazole derivatives. In 1H NMR spectra, aromatic protons usually appear as multiplets between about 6.5 and 8.5 ppm depending on substitution pattern. Imidazole N-H, if present, may appear as a broad downfield signal and can be confirmed by D2O exchange. Alkyl or methoxy substituents appear in their expected aliphatic regions and should integrate correctly.

13C NMR provides complementary evidence by showing imidazole ring carbons, aryl carbons and substituent carbons. In 2,4,5-triaryl imidazoles, carbon signals may overlap because of multiple aromatic rings, so careful assignment is required. DEPT, HSQC or HMBC may be added if the molecule is complex or if regioisomeric ambiguity is possible.

 

NMR signal type

Common observation

Manuscript significance

Aromatic protons

Multiplets around 6.5-8.5 ppm

Confirms aryl or heteroaryl substitution.

Imidazole N-H

Broad/exchangeable downfield signal

Supports unsubstituted N-H where expected.

Methoxy protons

Singlet around 3.7-3.9 ppm

Confirms OCH3-bearing derivatives.

Alkyl substituent

Aliphatic signals based on group pattern

Supports N-alkyl or side-chain substitution.

13C imidazole carbons

Downfield heteroaromatic carbons

Supports imidazole ring formation.

Carbonyl carbon

Usually downfield if retained in hybrid structures

Important for Schiff-base/acylated analogues.

 

The most useful NMR discussion connects spectral evidence with reaction outcome. For example, loss of aldehyde proton, correct integration of aromatic and substituent protons, and mass confirmation together provide stronger proof than listing unassigned chemical shifts.

11. Mass Spectrometry, Purity and Reporting Format:

Mass spectrometry is valuable for confirming molecular weight and, in halogenated imidazoles, characteristic isotope patterns. Chlorinated derivatives show M and M+2 peaks, while brominated derivatives show a more prominent M/M+2 pattern. Elemental analysis or high-resolution mass spectrometry can further support molecular formula. Purity must also be addressed before bioassay because unreacted aldehydes, catalysts or solvents may cause false-positive activity.

 

Compound code

Substituent type

Expected proof before assay

Result-reporting note

IMD-1

4-chloro phenyl

IR C=N, aryl protons, M/M+2 isotope pattern

Do not report activity without solvent control.

IMD-2

4-nitro phenyl

NO2 IR bands, deshielded aryl protons, correct MS

Discuss redox and toxicity concerns.

IMD-3

4-methoxy phenyl

OCH3 singlet, C-O band, correct molecular ion

Consider solubility and permeability balance.

IMD-4

Heteroaryl hybrid

Additional heteroaryl NMR pattern and MS

Mechanistic claim requires target assay.

IMD-5

Schiff-base imidazole

C=N band, imine proton/carbon signal, MS

Hydrolytic stability should be checked.

 

For an experimental manuscript, compound data should be presented as follows: yield, melting point, Rf value, IR peaks with assignment, 1H NMR with solvent, frequency and integration, 13C NMR with solvent and frequency, MS m/z value and elemental analysis. For a review manuscript, the same reporting format can be recommended without inventing values.

12. Antibacterial and Antifungal Activities:

Antimicrobial activity is one of the most frequently reported areas for substituted imidazoles. Testing usually includes Gram-positive organisms such as Staphylococcus aureus and Bacillus subtilis, Gram-negative organisms such as Escherichia coli, Pseudomonas aeruginosa and Klebsiella pneumoniae, and fungal strains such as Candida albicans, Aspergillus niger or Aspergillus fumigatus. [7-12]

Disc diffusion and well diffusion methods are useful for preliminary screening, but zone size depends on diffusion, solubility and agar interaction. MIC determination by broth dilution is more suitable for potency ranking. MBC and MFC values are needed when distinguishing bactericidal or fungicidal effects from simple growth inhibition. Current method references emphasize standardized inoculum, defined medium, incubation time, controls and reproducibility. [19-21,28,29]

 

Endpoint

Meaning

Required control/reporting detail

Zone of inhibition

Clear area around disc or well

Report concentration, solvent and standard drug.

MIC

Lowest concentration preventing visible growth

Report units and method; avoid clinical category unless breakpoint exists.

MBC

Lowest concentration killing bacteria on subculture

Report MBC/MIC ratio if possible.

MFC

Lowest concentration killing fungi on subculture

Use for fungicidal interpretation.

Solvent control

Effect of vehicle such as DMSO

Essential to prove compound-specific activity.

 

Antifungal imidazoles are classically associated with disruption of ergosterol biosynthesis through inhibition of lanosterol 14-alpha-demethylase, but novel imidazole derivatives should not be assumed to share this mechanism without biochemical or molecular confirmation. [22,23]

13. Other Biological Activities of Imidazole Derivatives:

Although antimicrobial activity is the main focus of many imidazole studies, the scaffold is pharmacologically broader. Imidazole derivatives have been reported in anti-inflammatory, analgesic, anticancer, antitubercular, antiviral, antidiabetic, antiulcer, antiparasitic and enzyme-inhibitory contexts. This broad profile occurs because imidazole can interact with diverse protein pockets and can be incorporated into molecules with different electronic and lipophilic profiles. [5,24-27]

 

Activity class

Representative design logic

Important caution

Antifungal

Azole-like interaction with sterol pathway or membrane targets

Mechanism requires sterol or enzyme evidence.

Antibacterial

Halogenated, nitro or hybrid imidazole analogues

MIC and cytotoxicity are required before lead claim.

Anti-inflammatory

Schiff-base or aryl-imidazole analogues designed for inflammatory targets

In vivo safety and COX/cytokine studies needed.

Anticancer

Cytotoxic or kinase/enzyme-targeted derivatives

Selectivity index against normal cells is essential.

Antitubercular

Lipophilic or nitrogen-rich analogues active against M. tuberculosis

Requires mycobacterial assay and safety profiling.

Antiviral

Target-guided imidazole design against viral enzymes

Docking alone is not biological proof.

 

A review-based activity discussion should separate actual experimental evidence from computational prediction. Docking and DFT can help explain binding hypotheses and electronic effects, but they cannot replace biological assays. A strong paper combines synthesis, full spectral proof, standardized in vitro testing, cytotoxicity and mechanistic validation.

14. Review-Based Results: Activity Mapping:

The review result indicates that substituted imidazole derivatives are not a single-activity class; rather, their activity depends on ring substitution, attached pharmacophore, electronic distribution, lipophilicity and assay design. Antibacterial and antifungal activities are the most frequently emphasized in the selected literature, while anti-inflammatory, anticancer, antitubercular and antiviral activities represent important extended pharmacological directions. [6-13,24-27]

 

Review result area

Observed pattern in literature

Interpretive conclusion

Synthetic accessibility

Multicomponent methods provide rapid library generation.

Imidazole is suitable for SAR-oriented medicinal chemistry.

Spectral proof

IR, NMR and MS are repeatedly used for confirmation.

Publication quality improves when peaks are assigned, not only listed.

Antibacterial profile

Halogenated and electron-withdrawing substituents often improve potency.

Electronic and lipophilic optimization is important.

Antifungal profile

Azole-related design remains relevant, especially for membrane/sterol targets.

Mechanistic proof is needed for novel derivatives.

Broader activity

Anti-inflammatory, anticancer, TB and antiviral reports are increasing.

Hybrid design expands biological scope.

Limitations

Poor solubility, absent cytotoxicity and weak controls are common.

Assay validity is as important as chemical novelty.

 

Overall, the review supports substituted imidazoles as promising lead-like scaffolds rather than finished therapeutic agents. The strongest future candidates will be those with low MIC or IC50 values, clear selectivity, acceptable solubility, reproducible synthesis, full spectral confirmation and target-based mechanistic evidence.

15. Structure-Activity Relationship:

SAR analysis connects structural features with biological response. In substituted imidazoles, the position and electronic character of substituents strongly affect potency. Electron-withdrawing groups such as nitro, chloro, bromo and trifluoromethyl may increase antimicrobial effects in some series by altering electron density, lipophilicity and target-binding interaction. However, the same groups may also increase toxicity or reduce solubility, so their effect must be evaluated case by case. [6,7,11]

 

Structural modification

Possible activity effect

Development concern

Halogen substitution

Improves lipophilicity and membrane interaction in many series.

May increase cytotoxicity or metabolic persistence.

Nitro substitution

May enhance antibacterial or antiprotozoal effect.

Redox toxicity and safety must be monitored.

Methoxy/hydroxy groups

Can improve binding or modulate solubility.

Position-dependent effects; not always potency-enhancing.

Heteroaryl hybrids

Add additional binding sites and pi-interactions.

More complex synthesis and characterization.

Bulky aryl rings

Increase hydrophobic target contacts.

May reduce water solubility and diffusion.

Schiff-base linkage

Adds imine-based pharmacophore and metal coordination possibility.

Hydrolytic stability requires study.

 

A practical SAR conclusion is that no single substituent guarantees activity. The best derivatives usually combine adequate lipophilicity, balanced polarity, stable structure, target-compatible geometry and acceptable safety. Therefore, future imidazole studies should include both potency and selectivity metrics.

16. DISCUSSION:

The reviewed evidence shows that imidazole derivatives remain attractive because they are synthetically accessible and biologically versatile. Classical Debus-Radziszewski condensation provides a convenient starting point for triaryl and related imidazoles, while modern green and assisted methods aim to improve sustainability and reaction efficiency. Hybrid design further expands biological relevance by combining the imidazole ring with other pharmacophores such as pyrazole, thiazole, Schiff bases, indole or aryl systems. [10-18]

The most common weakness in imidazole derivative manuscripts is incomplete integration of chemistry and biology. Some papers provide biological zones without adequate MIC values; others provide spectral data without clear peak assignment or purity evidence. A publishable manuscript should allow a reader to trace the compound from starting material to final activity result. That means the same compound code must appear consistently in synthesis, spectral tables and biological tables.

Another important issue is mechanism. Imidazole antifungal agents are often linked to ergosterol biosynthesis, but a newly synthesized derivative may act differently. Similarly, antibacterial activity may arise from membrane disruption, enzyme inhibition, metal chelation or redox stress. Therefore, molecular docking should be treated as a hypothesis-generating tool rather than final proof. Strong papers should add enzyme assay, membrane assay, microscopy, sterol quantification, resistance profiling or gene-expression studies where possible. [19-23]

The review-based result supports continued work on imidazole derivatives, especially when chemical design is guided by SAR and biological evaluation is standardized. Future manuscripts should avoid exaggerated clinical claims and should describe new molecules as hits or leads unless supported by in vivo efficacy, toxicity and pharmacokinetic data.

17. Limitations and Future Scope:

This manuscript is limited by its review-based nature. It does not report newly synthesized compounds, actual laboratory yields, melting points, spectral files or original MIC data. Therefore, its results should be understood as evidence synthesis and manuscript guidance. For a final experimental paper, each compound must be synthesized, purified and characterized independently, and activity must be tested under standardized conditions.

 

Limitation in many reports

Scientific risk

Recommended improvement

Only zone of inhibition reported

Diffusion may distort activity interpretation.

Add MIC, MBC or MFC with controls.

No purity proof before assay

Impurity may cause false activity.

Use TLC, melting point, IR, NMR and MS.

No solvent control

Vehicle may inhibit growth.

Include DMSO/blank control.

No cytotoxicity test

Active compound may be nonspecific toxicant.

Add mammalian cell viability assay.

Only docking study

Predicted binding may not occur biologically.

Add enzyme or cell-based validation.

Poor solubility discussion

Assay concentration may be unreliable.

Measure solubility or use formulation strategy.

 

Future scope should focus on designing imidazole hybrids with better selectivity, testing against resistant strains, including biofilm models, using cytotoxicity and hemolysis assays, applying ADMET prediction early, validating mechanisms experimentally and exploring nanoformulation strategies for poorly soluble leads. Green synthesis should be combined with true product quality and assay reproducibility.

 

CONCLUSION

Substituted imidazole derivatives represent an important and adaptable class of heterocyclic compounds in medicinal chemistry. Their value arises from the compact aromatic 1,3-diazole ring, the presence of two nitrogen atoms and the ability to introduce diverse substituents at multiple positions. This review manuscript summarizes the basic chemistry, synthesis, FT-IR and NMR characterization, biological activities, SAR observations and review-based results for substituted imidazole derivatives.

The review indicates that multicomponent synthesis, especially Debus-Radziszewski-type chemistry, remains a practical route for generating imidazole libraries. Green, microwave and ultrasound-assisted methods may improve efficiency when validated with yield, purity, catalyst reuse and safe work-up. Characterization should combine TLC, melting point, FT-IR, 1H NMR, 13C NMR, mass spectrometry and elemental or high-resolution mass analysis where possible.

Biologically, imidazole derivatives show strongest recurring relevance in antimicrobial and antifungal research, with additional activity reported in anti-inflammatory, anticancer, antitubercular and antiviral areas. The main review result is that activity is driven by substituent electronics, lipophilicity, hybrid pharmacophore design and assay validity. Electron-withdrawing groups, halogenated aryl rings and heteroaryl hybridization often improve activity, but safety, solubility and mechanism remain limiting factors.

A publishable imidazole manuscript should therefore integrate synthesis, spectral proof and biological testing into one reproducible scientific story. No compound should be advanced as a lead only on the basis of a zone of inhibition or docking score. The strongest future work will combine complete characterization, standardized MIC-based activity, cytotoxicity, ADMET evaluation and mechanism confirmation.

REFERENCES

  1. Grimmett MR. Imidazole and Benzimidazole Synthesis. London: Academic Press; 1997.
  2. Joule JA, Mills K. Heterocyclic Chemistry. 5th ed. Chichester: Wiley-Blackwell; 2010.
  3. Debus H. Ueber die Einwirkung des Ammoniaks auf Glyoxal. Ann Chem Pharm. 1858;107:199-208.
  4. Radziszewski B. Ueber Glyoxalin und seine Homologe. Ber Dtsch Chem Ges. 1882;15:1493-1496.
  5. Siwach A, Verma PK. Synthesis and therapeutic potential of imidazole containing compounds. BMC Chem. 2021;15:12.
  6. Andrei GS, Andrei BF, Pop RR. Imidazole derivatives and their antibacterial activity: a mini-review. Mini Rev Med Chem. 2021;21(11):1380-1392.
  7. Sharma D, Narasimhan B, Kumar P, Judge V, Narang R, De Clercq E, Balzarini J. Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives. Eur J Med Chem. 2009;44(6):2347-2353.
  8. Khan MS, Siddiqui SA, Siddiqui MSR, Goswami U, Srinivasan KV, Khan MI. Antibacterial activity of synthesized 2,4,5-trisubstituted imidazole derivatives. Chem Biol Drug Des. 2008;72(3):197-204.
  9. Gupta N, Pathak DP. Synthesis and evaluation of N-substituted imidazole derivatives for antimicrobial activity. Indian J Pharm Sci. 2011;73(6):674-678.
  10. Vijesh AM, Isloor AM, Telkar S, Peethambar SK, Rai S, Isloor N. Synthesis, characterization and antimicrobial studies of some new pyrazole incorporated imidazole derivatives. Eur J Med Chem. 2011;46(8):3531-3536.
  11. Liu C, Shi C, Mao F, Xu Y, Liu J, Wei B, et al. Discovery of new imidazole derivatives containing the 2,4-dienone motif with broad-spectrum antifungal and antibacterial activity. Molecules. 2014;19(10):15653-15672.
  12. Al-Ghamdi HA, Almughem FA, Alshabibi MA, Bakr AA, Alshehri AA, Aodah AH, et al. Synthesis and biological evaluation of novel imidazole derivatives as antimicrobial agents. Biomolecules. 2024;14(9):1198.
  13. Dwarakanath D, et al. Synthesis, characterization and in silico studies of novel imidazole-thiazole hybrids with antimicrobial and anticancer activity. Scientific Reports. 2025.
  14. Yu XL, et al. Synthesis of imidazole-based molecules under ultrasonic irradiation. Molecules. 2023;28:4535.
  15. Kerru N, Bhaskaruni SVHS, Gummidi L, Maddila SN, Maddila S, Jonnalagadda SB. Recent advances in heterogeneous catalysts for the synthesis of imidazole derivatives. Synth Commun. 2019;49(19):2437-2459.
  16. Pervaiz S, Raza A, Iqbal J, et al. Organocatalyzed solvent-free synthesis of 2,4,5-trisubstituted imidazoles. Chem Biodivers. 2020;17:e1900493.
  17. Maleki A, Paydar R. Graphene oxide-chitosan bionanocomposite as nanocatalyst for one-pot synthesis of trisubstituted imidazoles. RSC Adv. 2015;5:33177-33184.
  18. Ziarani GM, Badiei A, Dashtianeh Z, et al. One-pot synthesis of tetrasubstituted imidazoles using sulfonic acid functionalized silica. Arabian J Chem. 2013;6:453-458.
  19. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71-79.
  20. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48 Suppl 1:5-16.
  21. Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine MIC values. Nat Protoc. 2008;3(2):163-175.
  22. Ghannoum MA, Rice LB. Antifungal agents: mode of action and mechanisms of resistance. Clin Microbiol Rev. 1999;12(4):501-517.
  23. Borgers M. Mechanism of action of antifungal drugs with special reference to imidazole derivatives. Rev Infect Dis. 1980;2(4):520-534.
  24. Muheyuddeen G, et al. Design, synthesis and biological evaluation of novel imidazole derivatives as analgesic and anti-inflammatory agents. Scientific Reports. 2024;14:22799.
  25. Pandey J, Tiwari VK, Verma SS, et al. Synthesis and antitubercular screening of imidazole derivatives. Eur J Med Chem. 2009;44:3350-3355.
  26. Teli P, et al. Imidazole derivatives: impact and prospects in antiviral drug discovery. 2022.
  27. Burlacu AP, Dragan M, Oniga O, Matei MN, Oniga I, Lisa E, et al. Importance and involvement of imidazole structure in current and future therapy. Molecules. 2026;31(3):423.
  28. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 36th ed. CLSI supplement M100. Wayne, PA: CLSI; 2026.
  29. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 16.0. EUCAST; 2026.

Reference

  1. Grimmett MR. Imidazole and Benzimidazole Synthesis. London: Academic Press; 1997.
  2. Joule JA, Mills K. Heterocyclic Chemistry. 5th ed. Chichester: Wiley-Blackwell; 2010.
  3. Debus H. Ueber die Einwirkung des Ammoniaks auf Glyoxal. Ann Chem Pharm. 1858;107:199-208.
  4. Radziszewski B. Ueber Glyoxalin und seine Homologe. Ber Dtsch Chem Ges. 1882;15:1493-1496.
  5. Siwach A, Verma PK. Synthesis and therapeutic potential of imidazole containing compounds. BMC Chem. 2021;15:12.
  6. Andrei GS, Andrei BF, Pop RR. Imidazole derivatives and their antibacterial activity: a mini-review. Mini Rev Med Chem. 2021;21(11):1380-1392.
  7. Sharma D, Narasimhan B, Kumar P, Judge V, Narang R, De Clercq E, Balzarini J. Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives. Eur J Med Chem. 2009;44(6):2347-2353.
  8. Khan MS, Siddiqui SA, Siddiqui MSR, Goswami U, Srinivasan KV, Khan MI. Antibacterial activity of synthesized 2,4,5-trisubstituted imidazole derivatives. Chem Biol Drug Des. 2008;72(3):197-204.
  9. Gupta N, Pathak DP. Synthesis and evaluation of N-substituted imidazole derivatives for antimicrobial activity. Indian J Pharm Sci. 2011;73(6):674-678.
  10. Vijesh AM, Isloor AM, Telkar S, Peethambar SK, Rai S, Isloor N. Synthesis, characterization and antimicrobial studies of some new pyrazole incorporated imidazole derivatives. Eur J Med Chem. 2011;46(8):3531-3536.
  11. Liu C, Shi C, Mao F, Xu Y, Liu J, Wei B, et al. Discovery of new imidazole derivatives containing the 2,4-dienone motif with broad-spectrum antifungal and antibacterial activity. Molecules. 2014;19(10):15653-15672.
  12. Al-Ghamdi HA, Almughem FA, Alshabibi MA, Bakr AA, Alshehri AA, Aodah AH, et al. Synthesis and biological evaluation of novel imidazole derivatives as antimicrobial agents. Biomolecules. 2024;14(9):1198.
  13. Dwarakanath D, et al. Synthesis, characterization and in silico studies of novel imidazole-thiazole hybrids with antimicrobial and anticancer activity. Scientific Reports. 2025.
  14. Yu XL, et al. Synthesis of imidazole-based molecules under ultrasonic irradiation. Molecules. 2023;28:4535.
  15. Kerru N, Bhaskaruni SVHS, Gummidi L, Maddila SN, Maddila S, Jonnalagadda SB. Recent advances in heterogeneous catalysts for the synthesis of imidazole derivatives. Synth Commun. 2019;49(19):2437-2459.
  16. Pervaiz S, Raza A, Iqbal J, et al. Organocatalyzed solvent-free synthesis of 2,4,5-trisubstituted imidazoles. Chem Biodivers. 2020;17:e1900493.
  17. Maleki A, Paydar R. Graphene oxide-chitosan bionanocomposite as nanocatalyst for one-pot synthesis of trisubstituted imidazoles. RSC Adv. 2015;5:33177-33184.
  18. Ziarani GM, Badiei A, Dashtianeh Z, et al. One-pot synthesis of tetrasubstituted imidazoles using sulfonic acid functionalized silica. Arabian J Chem. 2013;6:453-458.
  19. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: a review. J Pharm Anal. 2016;6(2):71-79.
  20. Andrews JM. Determination of minimum inhibitory concentrations. J Antimicrob Chemother. 2001;48 Suppl 1:5-16.
  21. Wiegand I, Hilpert K, Hancock REW. Agar and broth dilution methods to determine MIC values. Nat Protoc. 2008;3(2):163-175.
  22. Ghannoum MA, Rice LB. Antifungal agents: mode of action and mechanisms of resistance. Clin Microbiol Rev. 1999;12(4):501-517.
  23. Borgers M. Mechanism of action of antifungal drugs with special reference to imidazole derivatives. Rev Infect Dis. 1980;2(4):520-534.
  24. Muheyuddeen G, et al. Design, synthesis and biological evaluation of novel imidazole derivatives as analgesic and anti-inflammatory agents. Scientific Reports. 2024;14:22799.
  25. Pandey J, Tiwari VK, Verma SS, et al. Synthesis and antitubercular screening of imidazole derivatives. Eur J Med Chem. 2009;44:3350-3355.
  26. Teli P, et al. Imidazole derivatives: impact and prospects in antiviral drug discovery. 2022.
  27. Burlacu AP, Dragan M, Oniga O, Matei MN, Oniga I, Lisa E, et al. Importance and involvement of imidazole structure in current and future therapy. Molecules. 2026;31(3):423.
  28. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 36th ed. CLSI supplement M100. Wayne, PA: CLSI; 2026.
  29. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 16.0. EUCAST; 2026.

Photo
Pawar Priti
Corresponding author

Dattakala college of pharmacy pune solapur highway swami-chincholi bhigwan tal- Daund Dist-Pune

Photo
Dr. Vishal Babar
Co-author

Dattakala College of Pharmacy Pune-Solapur Highway, Swami-Chincholi (Bhigwan), Tal-Daund, Dist-Pune, Maharashtra Pin code -413130.

Photo
Dr. Sudarshan Nagrale
Co-author

Dattakala College of Pharmacy Pune-Solapur Highway, Swami-Chincholi (Bhigwan), Tal-Daund, Dist-Pune, Maharashtra Pin code -413130.

Pawar Priti, Dr. Vishal Babar, Dr. Sudarshan Nagrale, Synthesis, Characterization and Biological Activities of Substituted Imidazole Derivatives: A Review, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 7, 1154-1166, https://doi.org/10.5281/zenodo.21218148

More related articles
Regulatory Process of Adverse Drug Reporting Case ...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykan...
Parkinson's Disease Beyond Dopamine: Integrating M...
Shubham Turewale, Mahesh Manke, Kiran surwase, Rushikesh choudhar...
Formulation And Development of Herbal Syrup for An...
Rameshwar Danave, Dr. Nilesh Chachda, Gaurav Meshram, Vaibhav Zot...
Stimuli-Responsive Hydrogel: An Overview...
Nityananda Mondal, Sanjiban Utpalkumar Sarkar, Kankana Koner, Arnab Bhunia, Niharika Sarkar, Suvodip...
Antibiotics Used in The Treatment of Diabetic Foot Infections...
Dt. Arifa Begum SK, V Priskilla, Y Srivani, V Tejaswi, S. Dhilip Kumar , Dr A Siva Prasad, Dr K V L ...
Antibiotics Used in The Treatment of Diabetic Foot Infections...
Dt. Arifa Begum SK, V Priskilla, Y Srivani, V Tejaswi, S. Dhilip Kumar , Dr A Siva Prasad, Dr K V L ...
Related Articles
A Comprehensive Review on Stability-Indicating RP-HPLC Methods for the Estimatio...
Komal Humbe, Dr. H. Kamble, Sugriv Ghodke, Sonawane A...
Method Development And Method Validation Of Oxycodone And Acetaminophen BY RP-...
Mohammad Irfan Sami, Dr. Iffath Rizwana, Sana Sultana, Wasifa Tabassum, Mirza Osman Baig...
Evaluation of Antimicrobial Potential and Cytotoxicity of Selected Marine Seawee...
Jisha Kumaran, Ayana N, Namitha R, Adhithya P, Arya K V...
Regulatory Process of Adverse Drug Reporting Case Studies in India...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykant Jadhav...
More related articles
Regulatory Process of Adverse Drug Reporting Case Studies in India...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykant Jadhav...
Parkinson's Disease Beyond Dopamine: Integrating Molecular Pathogenesis, Biomark...
Shubham Turewale, Mahesh Manke, Kiran surwase, Rushikesh choudhari, Dr. Padmaja Giram...
Formulation And Development of Herbal Syrup for Anxiety and Stress in Children...
Rameshwar Danave, Dr. Nilesh Chachda, Gaurav Meshram, Vaibhav Zotting...
Regulatory Process of Adverse Drug Reporting Case Studies in India...
Harshada Gore, Shraddha Ratanwar, Dr. Vijay Navghare, Dr. Surykant Jadhav...
Parkinson's Disease Beyond Dopamine: Integrating Molecular Pathogenesis, Biomark...
Shubham Turewale, Mahesh Manke, Kiran surwase, Rushikesh choudhari, Dr. Padmaja Giram...
Formulation And Development of Herbal Syrup for Anxiety and Stress in Children...
Rameshwar Danave, Dr. Nilesh Chachda, Gaurav Meshram, Vaibhav Zotting...